Inflammatory Bowel Disease Monitor - 2010 - Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

WEB LINKS

http://www.nature.com/nat
re/journal/v464/n7293/ful
/nature08949.html

Post Page On

Mesenchymal Stromal Cells in Crohn’s Disease

Marjolijn Duijvestein, MD, and Daniel W Hommes, MD, PhD

Inflammatory Bowel Disease Monitor

Lymphoma and IBD:  What is the Actual Risk? 

Guillaume Pineton de Chambrun, MD¹, Laurent Peyrin-Biroulet, MD², Bénédicte De Vroey, MD¹, and Jean-Frédéric Colombel, MD¹

Inflammatory Bowel Disease Monitor

Noninvasive Imaging in  Crohn’s Disease Assessment  

Emma Calabrese, MD, PhD, and Francesco Pallone, MD

Inflammatory Bowel Disease Monitor

Management of Severe Pediatric Ulcerative Colitis

Richard K Russell, PhD¹, and Dan Turner, MD, PhD²

Inflammatory Bowel Disease Monitor

Surgical Management of Stricturing Crohn’s Disease

Alex Tzivanakis MB, BS, BSc, MRCS, and Bruce George, MB, MS, BSc, FRCS

Inflammatory Bowel Disease Monitor

LATEST ARTICLES

Leading Articles
- IBD Medication Use in Pregnancy: A Review of Evidence For and Against
  
  Caroline Hwang, MD, and Uma Mahadevan, MD
  
  University of California–San Francisco, San Francisco, CA, USA
  
  Women with IBD are able to conceive at the same rate as women without IBD, but with an increased risk of adverse events. The biggest risk to pregnancy outcome, aside from a diagnosis of IBD, is disease activity. Therefore, continuing medications to maintain remission is important.
- Metabolomics and IBD
  
  Diane R Hildebrand, MB ChB, MRCS(Ed)¹, Natasha P Ross, MB ChB, MRCS(Ed)¹, and Angus JM Watson, MB ChB, FRCS(Ed), FRCS(Gen. Surg.)^1,2
  
  ¹Department of General Surgery, Raigmore Hospital, and ²University of Stirling, Inverness, Scotland, UK
  
  IBD is a chronic inflammatory condition with a high incidence in Northern Europe. Current biological markers are inadequate for detecting, phenotyping, and monitoring the disease. It is therefore imperative to find novel biomarkers that will not only help with diagnosis but that will also shed further light on the pathogenesis of IBD.
Clinical Reviews
Meeting Reports
- 1st British Society of Gastroenterology Supraregional Meeting
  
  Gareth-Rhys Jones, MBChB, BSc (Med Sci) Hons, MRCP
  
  Western General Hospital, Edinburgh, Edinburgh, UK
  Edinburgh, UK, September 15–16, 2011
  
  The inaugural supraregional meeting of the British Society of Gastroenterology was held in the scenic surroundings of Scotland’s capital, in the striking home of the Royal College of Physicians, Edinburgh. The conference boasted a number of domestic and international figures to address current thinking and pioneering research in pathogenesis within the field of IBD.
Commentary
- Pregnancy and Anti-TNF Use: Safety is Not Yet Assured
  
  C Janneke van der Woude, MD, PhD, and Zuzana Zelinkova, MD, PhD
  
  Department of Gastroenterology and Hepatology, ERASMUS MC, Rotterdam, The Netherlands
  
  In the Leading Article, IBD Medication Use in Pregnancy: Review of Evidence For and Against, presented in this issue of the IBD Monitor journal, Drs Caroline Hwang and Uma Mahadevan (University of California, San Francisco, CA, USA) offer an extensive overview that is undoubtedly useful for physicians managing IBD patients who wish to conceive.

Our most popular articles

READ

Is Diet Involved in the Etiology of Ulcerative Colitis and Crohn’s Disease? A Review of the Experimental and Epidemiological Literature
(Volume 12 Issue 1 / Leading Articles)
Adherent–Invasive Escherichia coli: Role in Crohn’s Disease Pathogenesis
(Volume 10 Issue 3 / Leading Articles)
Diagnosis and Management of Anemia in IBD
(Volume 11 Issue 4 / Leading Articles)
Enteral Nutrition in IBD
(Volume 09 Issue 4 / Leading Articles)
The Safety of Thiopurines: New Data, New Decisions
(Volume 10 Issue 4 / Leading Articles)
Metabolomics and IBD
(Volume 12 Issue 2 / Leading Articles)

British Society of Gastroenterology Annual Meeting 2011
(Volume 11 Issue 4 / Meeting Reports)
1st British Society of Gastroenterology Supraregional Meeting
(Volume 12 Issue 2 / Meeting Reports)

Is Diet Involved in the Etiology of Ulcerative Colitis and Crohn’s Disease? A Review of the Experimental and Epidemiological Literature
(Volume 12 Issue 1 / Leading Articles)
Metabolomics and IBD
(Volume 12 Issue 2 / Leading Articles)
Epidemiology
(Volume 12 Issue 2 / Clinical Reviews)

May 24, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

Inflammatory Bowel Disease Monitor

» Advanced search

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

Buonocore S, Ahern PP, Uhlig HH et al.

WEB LINKS

Post Page On

RELATED ARTICLES

Marjolijn Duijvestein, MD, and Daniel W Hommes, MD, PhD

Guillaume Pineton de Chambrun, MD¹, Laurent Peyrin-Biroulet, MD², Bénédicte De Vroey, MD¹, and Jean-Frédéric Colombel, MD¹

Emma Calabrese, MD, PhD, and Francesco Pallone, MD

Richard K Russell, PhD¹, and Dan Turner, MD, PhD²

Alex Tzivanakis MB, BS, BSc, MRCS, and Bruce George, MB, MS, BSc, FRCS

RELATED ARTICLES IN PUBMED

LATEST ARTICLES

Leading Articles

IBD Medication Use in Pregnancy: A Review of Evidence For and Against

Caroline Hwang, MD, and Uma Mahadevan, MD

Metabolomics and IBD

Diane R Hildebrand, MB ChB, MRCS(Ed)¹, Natasha P Ross, MB ChB, MRCS(Ed)¹, and Angus JM Watson, MB ChB, FRCS(Ed), FRCS(Gen. Surg.)^1,2

Clinical Reviews

Safety

Treatment

Pathogenesis

Epidemiology

Prognosis and assessment

Miscellaneous

Meeting Reports

1st British Society of Gastroenterology Supraregional Meeting

Gareth-Rhys Jones, MBChB, BSc (Med Sci) Hons, MRCP

Commentary

Pregnancy and Anti-TNF Use: Safety is Not Yet Assured

C Janneke van der Woude, MD, PhD, and Zuzana Zelinkova, MD, PhD

Our most popular articles


1 ratings / 5 average

May 24, 2012 CLOSE To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader. Produced and published by Remedica Medical Education and Publishing Limited. » Contact us

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

Buonocore S, Ahern PP, Uhlig HH et al.

WEB LINKS

Post Page On

RELATED ARTICLES

Marjolijn Duijvestein, MD, and Daniel W Hommes, MD, PhD

Guillaume Pineton de Chambrun, MD1, Laurent Peyrin-Biroulet, MD2, Bénédicte De Vroey, MD1, and Jean-Frédéric Colombel, MD1

Emma Calabrese, MD, PhD, and Francesco Pallone, MD

Richard K Russell, PhD1, and Dan Turner, MD, PhD2

Alex Tzivanakis MB, BS, BSc, MRCS, and Bruce George, MB, MS, BSc, FRCS

RELATED ARTICLES IN PUBMED

LATEST ARTICLES

Leading Articles

Caroline Hwang, MD, and Uma Mahadevan, MD

Diane R Hildebrand, MB ChB, MRCS(Ed)1, Natasha P Ross, MB ChB, MRCS(Ed)1, and Angus JM Watson, MB ChB, FRCS(Ed), FRCS(Gen. Surg.)1,2

Clinical Reviews

Meeting Reports

Gareth-Rhys Jones, MBChB, BSc (Med Sci) Hons, MRCP

Commentary

C Janneke van der Woude, MD, PhD, and Zuzana Zelinkova, MD, PhD

Our most popular articles

May 24, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

Guillaume Pineton de Chambrun, MD¹, Laurent Peyrin-Biroulet, MD², Bénédicte De Vroey, MD¹, and Jean-Frédéric Colombel, MD¹

Richard K Russell, PhD¹, and Dan Turner, MD, PhD²

Diane R Hildebrand, MB ChB, MRCS(Ed)¹, Natasha P Ross, MB ChB, MRCS(Ed)¹, and Angus JM Watson, MB ChB, FRCS(Ed), FRCS(Gen. Surg.)^1,2